- US12390419utility2025Formulations of (r)-2-amino-3-phenylpropyl Carbamate0 cites
- US12318362utility2025Methods of Providing Solriamfetol Therapy to Subjects with Impaired Renal Function0 cites
- US12263145utility2025Methods of Administering Solriamfetol to Lactating Women0 cites
- US12194016utility2025Methods of Providing Solriamfetol Therapy to Subjects with Impaired Renal Function0 cites
- US12102609utility2024Methods of Administering Solriamfetol to Lactating Women0 cites
- US12090126utility2024Methods of Administering Solriamfetol to Lactating Women0 cites
- US12064411utility2024Methods of Administering Solriamfetol to Lactating Women0 cites
- US12036194utility2024Methods of Administering Solriamfetol to Lactating Women0 cites
- US12005036utility2024Methods of Administering Solriamfetol to Lactating Women0 cites
- US11998639utility2024Formulations of (r)-2-amino-3-phenylpropyl Carbamate0 cites
- US11986454utility2024Methods of Providing Solriamfetol Therapy to Subjects with Impaired Renal Function0 cites
- US11986455utility2024Methods of Providing Solriamfetol Therapy to Subjects with Impaired Renal Function0 cites
- US11969404utility2024Methods of Providing Solriamfetol Therapy to Subjects with Impaired Renal Function0 cites
- US11872203utility2024Methods of Administering Solriamfetol to Lactating Women0 cites
- US11872204utility2024Methods of Administering Solriamfetol to Lactating Women0 cites
- US11865098utility2024Methods and Compositions for Treating Excessive Sleepiness0 cites
- US11857528utility2024Methods of Providing Solriamfetol Therapy to Subjects with Impaired Renal Function0 cites
- US11850226utility2023Methods of Providing Solriamfetol Therapy to Subjects with Impaired Renal Function0 cites
- US11850227utility2023Methods of Providing Solriamfetol Therapy to Subjects with Impaired Renal Function0 cites
- US11850228utility2023Methods of Providing Solriamfetol Therapy to Subjects with Impaired Renal Function0 cites
Page 1 of 2Next →